Important Announcement

Rayner Acquires Moorfields Pharmaceuticals

October 3, 2016 – Worthing, United Kingdom. Rayner, the pioneering manufacturer of intraocular lenses for cataract surgery, announced today that it has acquired Moorfields Pharmaceuticals.

The acquisition closed September 30, 2016.

Acquisition Details

Rayner has acquired Moorfields Pharmaceuticals from Moorfields Eye Hospital NHS Foundation Trust for an undisclosed price, for the purpose of launching a specialist ophthalmic pharmaceuticals division that will be expanded across Rayner’s direct presence in Europe.

Members of the Moorfields Pharmaceuticals team will transfer to Rayner however they will continue to be based in London and will be shortly moving to a new office.

Commenting on the acquisition, Rayner CEO, Tim Clover, remarked, “We are committed to supporting ophthalmologists in attaining the best outcomes for their patients.  Although the intraocular lens plays a leading role in the visual outcomes of cataract and refractive surgery, the pharmaceuticals that manage the tear film and inflammation are critical to the end result.  For that reason, the acquisition of Moorfields Pharmaceuticals will enable us to offer an even wider range of ophthalmic tools that aid and streamline the surgical process whilst remaining focused on the visual outcome for the patient. We are delighted to welcome Moorfields Pharmaceuticals to the Rayner team.”

David Probert, chief executive of Moorfields Eye Hospital NHS Foundation Trust, said: “Following a detailed strategic review, we have taken the decision to sell Moorfields Pharmaceuticals. We believe Rayner will enable the pharmaceutical business to grow and ensure that its products are available for many years to come.”

Alan Krol, managing director of Moorfields Pharmaceuticals, said: “Both Moorfields Pharmaceuticals and Rayner have a long and distinguished history in providing innovation, customer choice and value to the eye care community. Together we will be able to deliver existing and new products to our customers which will improve the care of patients. We are delighted to be joining forces with Rayner.”

For more information please go to www.rayner.com

- ENDS -

About Rayner

Since the implantation of the first intraocular lens by Sir Harold Ridley 1949, Rayner has continuously pioneered intraocular lens (IOL) design with a goal to improve vision and restore sight worldwide. Today, Rayner’s mission remains to deliver innovative and clinically superior ophthalmic products that respond to the expectations of our global customers to improve the sight and quality of life of their patients.

Headquartered in Worthing, United Kingdom, Rayner markets its IOL portfolio and related products worldwide in over 80 countries through a network of distributors and includes direct sales teams in the United Kingdom, USA, Germany & Austria, Italy and Spain.

 

About Moorfields Pharmaceuticals

Moorfields Pharmaceuticals was launched as the pharmaceutical manufacturing division of Moorfields Eye Hospital NHS Foundation Trust in 2004. Moorfields Pharmaceuticals has developed a portfolio of innovative eye care solutions which offer high quality and value for money options for treating common eye conditions as well as rarer diseases.

For more information, please visit: www.moorfieldspharmaceuticals.co.uk

 

About Moorfields Eye Hospital NHS Foundation Trust

  • Moorfields is the leading provider of eye health services in the UK and a world-class centre of excellence for ophthalmic research and education. Our main focus is the treatment and care of NHS patients with a wide range of eye problems, from common complaints to rare conditions that require treatment not available elsewhere in the UK. Our unique patient case-mix and the number of people we treat mean that our clinicians have expertise in discrete ophthalmic sub-specialties.
  • We treat people in 32 locations in and around London enabling us to provide expert treatment closer to patients’ homes. We also operate commercial divisions that provide care to private patients in both London and the Middle East. 
  • For further information, please visit www.moorfields.nhs.uk

 

For general enquiries, please contact Rayner: iol_enquiries@rayner.com

Not all Rayner products are approved for sale in every country. Please contact your local Rayner distributor for details of which products are available in your area.

©2016 Rayner. EC201691.

 
How to Order

Ordering details

- Call us: 020 7684 9090